Skip to main content
. 2010 Sep 7;4:203–220. doi: 10.2147/DDDT.S12056

Figure 1.

Figure 1

Site of action of glycoprotein IIb/IIa inhibitors.

Aggregation requires activated platelets, glycoprotein receptor IIb/IIIa (GP), and fibrinogen. The latter acts as a bridge that attaches platelet to each other forming the initial hemostatic plug. The current ACC/AHA guidelines recommend the use of GP IIb/IIa antagonists in high-risk patients with STEMI-ACS and planned percutaneous coronary intervention.